Cardiovascular care professionals must consider the concerns and views of healthcare workers, members of hospital/health system leadership and, not least, patients—whether the latter are infected with COVID-19 or not.

Americans are dying from cardiovascular disease (CVD) caused or exacerbated by hypertension at alarmingly higher rates than in years past.

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.

When evaluating a pediatric patient for hypertension, healthcare providers often monitor the child’s blood pressure for a 24-hour period. However, according to new findings published in the Clinical Journal of the American Society of Nephrology, such “blood pressure load” assessments may not provide significant value.  

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

Of COVID-19 patients who develop serious heart complications, most don’t see this problem until late in the disease’s progression. However, some are turning up with extensive heart inflammation at the outset.

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.